Efficacy for Bone Deterioration in Mice with Osteoporosis and Pharmaceutical Properties of a Novel Compound Calcium Carbonate Granule

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td class="align_left">Excipients</td><td class="align_center">Name</td><td class="align_center">Proportion (compared to calcium carbonate)</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td class="align_left">Effervescent agents</td><td class="align_center">Citric acid, malic acid, tartaric acid, or their combination</td><td class="align_center">1∼2</td></tr><tr><td class="align_left">Binders</td><td class="align_center">PVP, HPMC, or combination</td><td class="align_center">0.01∼0.4</td></tr><tr><td class="align_left">Fillers</td><td class="align_center">Lactose, sorbitol, mannitol, MCC, icing sugar, or their combination</td><td class="align_center">15∼40% total mass</td></tr><tr><td class="align_left">Flavouring agents</td><td class="align_center">Aspartame, sucrose, stevioside, sorbitol, or their combination</td><td class="align_center">1∼20% total mass</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Excipients used in CCCG manufacturing.</div>

Journal of Food Biochemistry

tab1

Table 1

Table 1: Efficacy for Bone Deterioration in Mice with Osteoporosis and Pharmaceutical Properties of a Novel Compound Calcium Carbonate Granule 